Yeast expressed recombinant Hemagglutinin protein of Novel H1N1 elicits neutralising antibodies in rabbits and mice

Virology Journal

Volumn 8, Issue , 2011, Pages

  Athmaram, T N ^a   Saraswat, Shweta ^a   Santhosh, S R ^b   Singh, Anil ^a   Suryanarayana, Vvs ^c   Priya, Raj ^a   Gopalan, N ^a   Parida, Manmohan ^a   Lakshmana Rao, P V ^a   Vijayaraghavan, R ^a  

^a DEFENCE RESEARCH AND DEVELOPMENT ESTABLISHMENT   (India)

^b Institute of Aerospace Medicine   (India)

^c INDIAN VETERINARY RESEARCH INSTITUTE   (India)

Author keywords

H1N1; Hemagglutinin; Influenza recombinant vaccine; Pichia pastoris; secreted expression

Indexed keywords

HEMAGGLUTININ; NEUTRALIZING ANTIBODY; SYNTHETIC DNA; TRYPSIN; VACCINE;

ANIMAL EXPERIMENT; ARTICLE; BIOSYNTHESIS; CONTROLLED STUDY; EXPERIMENTAL MOUSE; EXPERIMENTAL RABBIT; FAST PROTEIN LIQUID CHROMATOGRAPHY; GENOME; HEMAGGLUTINATION; IMMUNIZATION; INFLUENZA VIRUS A H1N1; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PICHIA PASTORIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN PURIFICATION; PROTEIN SECRETION; VIRUS GENE; WESTERN BLOTTING; YEAST;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; FEASIBILITY STUDIES; HEMAGGLUTINATION INHIBITION TESTS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; MALE; MICE; PICHIA; RABBITS; RECOMBINANT FUSION PROTEINS; VACCINES, SYNTHETIC;

ANIMALIA; BACTERIA (MICROORGANISMS); MUS; ORYCTOLAGUS CUNICULUS; PICHIA; PICHIA PASTORIS;

EID: 84855446842     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-8-524     Document Type: Article

References (54)

1. Dating the emergence of pandemic influenza viruses. Bahl J, Vijaykrishna D, Zhang J, Poon LL, Proc Natl Acad Sci USA 2009 106 11709 11712 10.1073/pnas.0904991106 19597152
2. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Smith GJ, Vijaykrishna D, Bahl J, Lycett SJ, Worobey M, Nature 2009 459 1122 1125 10.1038/nature08182 19516283
3. Triple reassortant swine influenza A (H1) in humans in the United States, 2005-2009. Shinde V, Bridges CB, Uyeki TM, Shu B, Balish A, N Engl J Med 2009 360 2616 2625 10.1056/NEJMoa0903812 19423871
4. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Skehel JJ, Wiley DC, Annu Rev Biochem 2000 69 531 569 10.1146/annurev.biochem.69.1.531 10966468
5. Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme. White JM, Delos SE, Brecher M, Schornberg K, Crit Rev Biochem Mol Biol 2008 43 189 219 10.1080/10409230802058320 18568847 (Pubitemid 351883153)
6. Structural identification of the antibody binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Wiley DC, Wilson IA, Skehel JJ, Nature 1981 289 373 378 10.1038/289373a0 6162101 (Pubitemid 11135143)
7. The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Caton AJ, Brownlee GG, Yewdell JW, Gerhard W, Cell 1982 31 417 427 10.1016/0092-8674(82)90135-0 6186384 (Pubitemid 13178866)
8. Cross-Neutralizing Antibodies to Pandemic 2009 H1N1 and Recent Seasonal H1N1 Influenza A Strains Influenced by a Mutation in Hemagglutinin Subunit 2. Wang W, Anderson CM, De Feo CJ, Zhuang M, Yang H, PLoS Pathog 2011 7 6 1002081 10.1371/journal.ppat.1002081 21695241
9. Strategies for achieving high-level expression of genes in Escherichia coli. Makrides SC, Microbiol Rev 1996 60 512 8840785
10. The purification of eukaryotic polypeptides synthesized in Escherichia coli. Marston FA, Biochem J 1986 240 1 12 3548705
11. Chaperone-assisted protein expression. Cole PA, Structure 1996 4 239 242 10.1016/S0969-2126(96)00028-7 8805540 (Pubitemid 3036557)
12. Expression of highly disulfide-bonded proteins in Pichia pastoris. White CE, Kempi NM, Komives EA, Structure; 1994 2 1003 1005 10.1016/S0969-2126(94) 00103-0 22125739 (Pubitemid 2164561)
13. A system for dual protein expression in Pichia pastoris and Escherichia coli. Lueking A, Holz C, Gotthold C, Lehrach H, Cahill D, Protein Express Purif 2000 20 372 378 10.1006/prep.2000.1317
14. Effect of the extra N terminal methionine residue on the stability and folding of recombinant alpha-lactalbumin expressed in Escherichia coli. Chaudhuri TK, Horii K, Yoda T, Arai M, Nagata S, J Mol Biol 1999 285 1179 1194 10.1006/jmbi.1998.2362 9887272 (Pubitemid 29054325)
15. Effect of foreign N-terminal residues on the conformational stability of human lysozyme. Takano K, Tsuchimori K, Yamagata Y, Yutani K, Eur J Biochem 1999 266 675 682 10.1046/j.1432-1327.1999.00918.x 10561612
16. Comparing the antibody responses against recombinant hemagglutinin proteins of avian influenza A (H5N1) virus expressed in insect cells and bacteria. Shen S, Mahadevappa G, Oh HL, Wee BY, Choi YW, J Med Virol 2008 80 1972 1983 10.1002/jmv.21298 18814259
17. Immunological study of HA1 domain of hemagglutinin of influenza H5N1 virus. Chiu FF, Venkatesan N, Wu CR, Chou AH, Chen HW, Biochem Biophys Res Commun 2009 383 27 31 10.1016/j.bbrc.2009.03.106 19324009
18. Preparation, characterization, and immunogenicity in mice of a recombinant influenza H5 hemagglutinin vaccine against the avian H5N1 A/Vietnam/1203/2004 influenza virus. Biesova Z, Miller MA, Schneerson R, Shiloach J, Green KY, Vaccine 2009 27 6234 6238 10.1016/j.vaccine.2009.07.107 19686692
19. Isotopically labeled expression in E. coli, purification, and refolding of the full ectodomain of the influenza virus membrane fusion protein. Curtis-Fisk J, Spencer RM, Weliky DP, Protein Expr Purif 2008 61 212 219 10.1016/j.pep.2008.06.009 18640277
20. Preparation and immune activity analysis of H5N1 subtype avian influenza virus recombinant protein based vaccine. Xie QM, Ji J, Du LQ, Cao YC, Wei L, Poult Sci 2009 88 1608 1615 10.3382/ps.2009-00092 19590075
21. Sambrook J, Russell DW, Molecular Cloning: A Laboratory Manual New York, USA: Cold Spring Harbor Laboratory Press 2002
22. Expression and refolding of functional fragments of the human lipopolysaccharide receptor CD14 in Escherichia coli and Pichia pastoris. Majerle A, Kidric J, Jerala R, Protein Express Purif 1999 17 96 104 10.1006/prep.1999.1109 (Pubitemid 29504383)
23. Expression vectors for affinity purification and radiolabeling of proteins using Escherichia coli as host. Chen BP, Hai T, Gene 1994 139 73 75 10.1016/0378-1119(94)90525-8 8112591 (Pubitemid 24086741)
24. Construction of an expression system of insect lysozyme lacking thermal stability: the effect of selection of signal sequence on level of expression in the Pichia pastoris expression system. Koganesawa N, Aizawa T, Masaki K, Matsuura A, Nimori T, Protein Engng 2001 14 705 710 10.1093/protein/14.9.705 (Pubitemid 33086292)
25. Glycosylation of prourokinase produced by Pichia pastoris impairs enzymatic activity but not secretion. Wang P, Zhang J, Sun ZY, Chen YH, Liu JN, Protein Express Purif 2000 20 179 185 10.1006/prep.2000.1310
26. Secretion of a variant of human single-chain urokinase type plasminogen activator without an N-glycosylation site in the methylotrophic yeast, Pichia pastoris and characterization of the secreted product. Tsujikawa M, Okabayashi K, Morita M, Tanabe T, Yeast 1996 12 541 553 10.1002/(SICI)1097-0061(199605)12: 6<541::AID-YEA935>3.0.CO;2-A 8771709
27. Evaluation of a recombinant hemagglutinin expressed in insect cells as an influenza vaccine in young and elderly adults. Treanor JJ, Betts RF, Smith GE, Anderson EL, Hackett CS, J Infect Dis 1996 173 1467 1470 10.1093/infdis/173.6. 1467 8648221 (Pubitemid 26286808)
28. Dose related safety and immunogenicity of a trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine in elderly adults. Treanor JJ, Schiff GM, Couch RB, Cate TR, Brady RC, J Infect Dis 2006 193 1223 1228 10.1086/503050 16586358
29. Comparative efficacy of neutralizing antibodies elicited by recombinant hemagglutinin proteins from avian H5N1 influenza virus. Wei CJ, Xu L, Kong WP, Shi W, Canis K, J Virol 2008 82 6200 6208 10.1128/JVI.00187-08 18417563 (Pubitemid 351875101)
30. Production of Insulin-Like Growth Factor-1 in Methylotrophic Yeast Cells. Brierley RA, Davis GR, Holtz GC, United States Patent 5,324,639 1994
31. High-level Expression of Tetanus Toxin Fragment c in Pichia pastoris Strains Containing Multiple Tandem Integrations of the Gene. Clarec JJ, Rayment FB, Ballantine SP, Sreekrishna K, Romanos MA, Bio/Technol 1991 9 455 460 10.1038/nbt0591-455
32. Recent Advances in the Expression of Foreign Genes in Pichia pastoris. Cregg JM, Vedvick TS, Raschke WC, Bio/Technol 1993 11 905 910 (Pubitemid 23218978)
33. Recombinant Bordetella pertussis Pertactin p69 from the Yeast Pichia pastoris High Level Production and Immunological Properties. Romanos MA, Clare JJ, Beesley KM, Rayment FB, Ballantine SP, Vaccine 1991 9 901 906
34. The Intracellular Production and Secretion of HIV-1 Envelope Protein in the Methylotrophic Yeast Pichia pastoris. Scorer CA, Buckholz RG, Clare JJ, Romanos MA, Gene 1993 136 111 119 10.1016/0378-1119(93)90454-B 8293993 (Pubitemid 24049229)
35. Rapid Selection Using G418 of High Copy Number Transformants of Pichia pastoris for High-level Foreign Gene Expression. Scorer CA, Clare JJ, McCombie WR, Romanos MA, Sreekrishna K, Bio/Technol 1994 12 181 184 10.1038/nbt0294-181 (Pubitemid 24045353)
36. High-level Secretion of Biologically Active Aprotonin from the Yeast Pichia pastoris. Vedvick T, Buckholz RG, Engel M, Urcan M, Kinney J, J Ind Microbiol 1991 7 197 201
37. Advances in the production of human therapeutic proteins in yeasts and filamentous fungi. Gerngross TU, Nature biotechnol 2004 22 11 1409 1414 10.1038/nbt1028 (Pubitemid 39482860)
38. Use of combinatorial genetic libraries to humanize N-linked glycosylation in the yeast Pichia pastoris. Choi BK, Bobrowicz P, Davidson RC, Hamilton SR, Kung DH, Proc Nat Acad Sci USA 2003 100 9 5022 5027 10.1073/pnas.0931263100 12702754 (Pubitemid 36546252)
39. Production of complex human glycoproteins in yeast. Hamilton SR, Bobrowicz P, Bobrowicz B, Davidson RC, Li H, Science 2003 301 5637 1244 1246 10.1126/science.1088166 12947202 (Pubitemid 37052215)
40. Engineering of an artificial glycosylation pathway blocked in core oligosaccharide assembly in the yeast Pichia pastoris: production of complex humanized glycoproteins with terminal galactose. Bobrowicz P, Davidson RC, Li H, Potgieter TI, Nett JH, Hamilton SR, Glycobiol 2004 14 9 757 766 10.1093/glycob/cwh104 (Pubitemid 39206878)
41. Production of Epidermal Growth Factor in Yeast: High-Level Secretion Using Pichia pastoris Strains Containing Multiple Gene Copies. Clare JJ, Romanos MA, Rayment FB, Rowedder JE, Smith MA, Gene 1991 105 205 212 10.1016/0378-1119(91)90152-2 1937016
42. Expression of recombinant Bluetongue VP2 protein in Pichia pastoris. Athmaram TN, Geetha Bali, Sulatha D, Virus Genes 2007 35 2 265 267 10.1007/s11262-006-0061-0 17253126 (Pubitemid 47087529)
43. Functional phytohemagglutinin (PHA) and Galanthus nivalis agglutinin (GNA) expressed in Pichia pastoris-correct N-terminal processing and secretion of heterologous proteins expressed using the PHA-E signal peptide. Raemaekers RJM, de Muro L, Gatehouse JA, Fordham-Skelton AP, Eur J Biochem 1999 265 394 403 10.1046/j.1432-1327.1999.00749.x 10491197 (Pubitemid 29466050)
44. Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus based immunization. Gao W, Soloff AC, Lu X, Montecalvo A, Nguyen DC, J Virol 2006 80 1959 1964 10.1128/JVI.80.4.1959-1964.2006 16439551 (Pubitemid 43228735)
45. Properly Folded Bacterially Expressed H1N1 Hemagglutinin Globular Head and Ectodomain Vaccines Protect Ferrets against H1N1 Pandemic Influenza Virus. Surender K, Swati V, Nitin V, Corey Crevar J, Carter Donald M, PLoS ONE 2010 5 11548 10.1371/journal.pone.0011548 20634959
46. Efficacious Recombinant Influenza Vaccines Produced by High Yield Bacterial Expression: A Solution to Global Pandemic and Seasonal Needs. Langzhou S, Valerian N, Uma K, Albert P, Jim H, PLoS ONE 2008 3 2257 10.1371/journal.pone.0002257 18493310
47. Signal processing, glycosylation and secretion of mutant hemagglutinins of a human influenza virus by Saccharomyces cerevisiae. Jabbar MA, Nayak DP, Mol Cell Biol 1987 7 1476 1485 3037322 (Pubitemid 17045238)
48. Protection of mice against a lethal influenza virus challenge after immunisation with yeast derived secreted Influenza virus Hemagglutinin. Saelens Xavier, Van landschoot Peter, Martinet Wim, Maras Marleen, neirynck Sabine, Contreras Roland, Fiers Walter, Jou Min Willy, Eur J Biochem 1999 260 166 175 10.1046/j.1432-1327.1999.00150.x 10091596 (Pubitemid 29095707)
49. Reduced extracellular pH reversibly inhibits oligomerization, intracellular transport and processing of influenza Hemagglutinin in infected Madin-Darby Canine Kidney cells. Matlin KS, Skibbens J, McNeil PC, J Biol Chem 1988 263 11478 11485 3042769
50. Recent advances in the expression of foreign genes in Pichia Pastoris. Cregg JM, Vedvick TS, Raschke WC, BioTechnol 1993 11 905 910 10.1038/nbt0893-905 (Pubitemid 23218978)
51. Production of foreign proteins in the yeast Pichia pastoris. Cregg JM, Higgins DR, Can J Bot 1995 73 891 897
52. Quality and authenticity of heterologous proteins synthesized in yeast. Eckart MR, Bussineau CM, Curr Opin Biotechnol 1996 7 525 530 10.1016/S0958-1669(96)80056-5 8939630 (Pubitemid 26381755)
53. The intracellular production and secretion of HIV-1 envelope protein in the methylotrophic yeast Pichia pastoris. Scorer CA, Buckholz RG, Clare JJ, Romanos MA, Gene 1993 136 111 119 10.1016/0378-1119(93)90454-B 8293993 (Pubitemid 24049229)
54. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Bradford MM, Anal Biochem 1976 72 248 254 10.1016/0003-2697(76)90527-3 942051